Molecular Docking and Antihypertensive Activity of Eupalitin 3-O-β-D-galactopyranoside Isolated from Boerhavia diffusa Linn
2024

Antihypertensive Effects of Eupalitin 3-O-β-D-galactopyranoside from Boerhavia diffusa

Sample size: 28 publication 10 minutes Evidence: moderate

Author Information

Author(s): Uoorakkottil Ilyas, Koottangodan Rashid, Thajudheen Kamal Y., Alsheri Saad Ali, Ahmed Mohammed Muqtader

Primary Institution: Moulana College of Pharmacy, Perinthalmanna, India

Hypothesis

Does eupalitin 3-O-β-D-galactopyranoside exhibit antihypertensive activity in hypertensive rats?

Conclusion

Eupalitin 3-O-β-D-galactopyranoside significantly reduces blood pressure in hypertensive rats, indicating its potential as a natural treatment for hypertension.

Supporting Evidence

  • Eupalitin 3-O-β-D-galactopyranoside significantly lowered both systolic and diastolic blood pressure in hypertensive rats.
  • The compound showed a dose-dependent response in reducing blood pressure.
  • Pharmacokinetic studies indicated moderate bioavailability of eupalitin 3-O-β-D-galactopyranoside.

Takeaway

A natural compound from a plant can help lower high blood pressure in rats, which might help people with hypertension too.

Methodology

The study involved isolating eupalitin 3-O-β-D-galactopyranoside from Boerhavia diffusa, inducing hypertension in rats, and measuring blood pressure changes after treatment with the compound.

Potential Biases

Potential biases in animal selection and treatment allocation were assessed using SYRCLE’s Risk of Bias tool.

Limitations

The study was limited to a specific animal model and did not explore the toxicity profiles of the compound.

Participant Demographics

Albino rats weighing 100-200 g were used in the study.

Statistical Information

P-Value

<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.3390/pharmaceutics16121628

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication